These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14980914)

  • 1. Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects.
    Callahan RJ; Au JD; Paul M; Liu C; Yost CS
    Anesth Analg; 2004 Mar; 98(3):653-9, table of contents. PubMed ID: 14980914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
    J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Buller AL; Larson HC; Morrisett RA; Monaghan DT
    Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes.
    Kuner T; Schoepfer R; Korpi ER
    Neuroreport; 1993 Dec; 5(3):297-300. PubMed ID: 7905294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Cruz SL; Mirshahi T; Thomas B; Balster RL; Woodward JJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):334-40. PubMed ID: 9655877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
    J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists.
    Hansen KB; Mullasseril P; Dawit S; Kurtkaya NL; Yuan H; Vance KM; Orr AG; Kvist T; Ogden KK; Le P; Vellano KM; Lewis I; Kurtkaya S; Du Y; Qui M; Murphy TJ; Snyder JP; Bräuner-Osborne H; Traynelis SF
    J Pharmacol Exp Ther; 2010 Jun; 333(3):650-62. PubMed ID: 20197375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of methadone and its isomers.
    Inturrisi CE
    Minerva Anestesiol; 2005; 71(7-8):435-7. PubMed ID: 16012416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of µ-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus.
    Matsui A; Williams JT
    Br J Pharmacol; 2010 Nov; 161(6):1403-13. PubMed ID: 20659105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit-dependent inhibition of recombinant rodent N-methyl-D-aspartate receptors by a HIV-1 glycoprotein 120 derived peptide.
    Wittekindt B; Betz H; Laube B
    Neurosci Lett; 2000 Feb; 280(2):151-4. PubMed ID: 10686400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys.
    Blanchet PJ; Konitsiotis S; Whittemore ER; Zhou ZL; Woodward RM; Chase TN
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1034-40. PubMed ID: 10454475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    Cruz SL; Balster RL; Woodward JJ
    Br J Pharmacol; 2000 Dec; 131(7):1303-8. PubMed ID: 11090101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.